Pharmacokinetic study of triptolide, a constituent of immunosuppressive Chinese herb medicine, in rats

Biological and Pharmaceutical Bulletin

Volumn 30, Issue 4, 2007, Pages 702-707

  Shao, Feng ^a   Wang, Guangji ^a   Xie, Haitang ^a   Zhu, Xiaoyan ^a   Sun, Jianguo ^a   Jiye, A ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

HPLC; LC MS; Pharmacokinetics; Triptolide

Indexed keywords

TRIPTOLIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG BILE LEVEL; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG DOSAGE FORM COMPARISON; DRUG ELIMINATION; DRUG FECES LEVEL; DRUG HALF LIFE; DRUG METABOLISM; DRUG URINE LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; NONHUMAN; RAT; TISSUE DISTRIBUTION;

ADMINISTRATION, ORAL; ANIMALS; CHROMATOGRAPHY, LIQUID; DITERPENES; DRUGS, CHINESE HERBAL; EPOXY COMPOUNDS; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, INTRAVENOUS; MALE; MASS SPECTROMETRY; PHENANTHRENES; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION;

EID: 34147187917     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.30.702     Document Type: Article

References (20)

1. Lipsky P. E., Tao X. L., Semin Arthritis Rheum, 26, 713-723 (1997).
2. Tao X. L., Sun Y., Dong Y., Xiao Y. L., Hu D. W., Shi Y. P., Chin. Med. J., 102, 327-332 (1989).
3. Ho L. J., Chang D. M., Chang M. L., J. Rheumatol., 26, 14-24 (1999).
4. Li X. W., Weir M. R., Transplantation, 50, 82-86 (1990).
5. Qiu D., Kao P. N., Drugs R D, 4, 1-18 (2003).
6. Liu J., Wu Q. L., Feng Y. H., Acta Pharmacol. Sin., 26, 223-227 (2005).
7. Tao X., Lipsky P. E., Rheum Dis. Clin. North Am., 26, 29-50 (2000).
8. Zhang L., Zhang Z. X., Sheng L. S., J. China Pharmaceut. Univ., 23, 158-160 (1992).
9. Gu W. Z., Brandwein S. R., Int. J. Immunopharmacol., 20, 389-400 (1998).
10. Li L., Wakukami T., Teng W. P., Di G. X., Murakami K., Mimura G., Chin. J. Diabetes, 2, 69-75 ( 1994).
11. Su D., Song Y., Li R., Chin. J. Integrated Trad. West Med., 10, 144-146 (1990).
12. Yi Z. W., Li L., Hunan Med. J., 11, 284-285 (1994).
13. Lu H., Hachida M., Enosawa S., Li X. K., Suzuki S., Koyanagi H., Transplant Proc., 31, 2056-2057 (1999).
14. Chan M. A., Kohlmeier J. E., Branden M., Jung M., Benedict S. H., Phytother. Res., 13, 464-467 (1999).
15. Yang Y., Liu Z., Tolosa E., Yang J., Li L., Immunopharmacology, 40, 139-149 (1998).
16. Li P., Chen G., Zhao Y. R., Adverse Drug Reactions J., 4, 238-240 (2002).
17. Qui Y. W., Wu S. W., Wu X. R., J. TCM Univ. of Human, 25, 62-64 (2005).
18. Sun X., Zhang S. M., Tian C. H., Chinese J. New Drugs, 10, 539-543 (2001).
19. Ding H., Wu J. Y., Tong J., Chin. Tradit. Herb Drugs, 27, 115-118 (2004).
20. Shao F., Wang G. G., Sun J. G., J. Pharm. Biomed. Anal., 41, 341-346 (2006).